COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,014 Articles (22,627 medRxiv, 8,387 bioRxiv)

Most recent first Previous |  Page 2291: Articles 22901-22910  | Next

SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia
Chong, Y. M., Sam, I.-C., Chong, J., Kahar Bador, M., Ponnampalavanar, S., Syed Omar, S. F., Kamarulzaman, A., Munusamy, V., Wong, C. K., Jamaluddin, F. H., Chan, Y. F.
10.1101/2020.08.27.269738 — Posted: 2020-08-27
Compositional Variability and Mutation Spectra of Monophyletic SARS-CoV-2 Clades
Teng, X., Li, Q., Li, Z., Zhang, Y., Niu, G., Zhang, M., Xiao, J., Yu, J., Zhang, Z., Song, S.
10.1101/2020.08.26.267781 — Posted: 2020-08-27
Structure of SARS-CoV-2 ORF8, a rapidly evolving coronavirus protein implicated in immune evasion
Flower, T. G., Buffalo, C. Z., Hooy, R. M., Allaire, M., Ren, X., Hurley, J. H.
10.1101/2020.08.27.270637 — Posted: 2020-08-27
The Coronavirus Health and Impact Survey (CRISIS) reveals reproducible correlates of pandemic-related mood states across the Atlantic.
Nikolaidis, A., Paksarian, D., Alexander, L., DeRosa, J., Dunn, J., Nielson, D. M., Droney, I., Kang, M., Douka, I., Bromet, E., Milham, M. P., Stringaris, A., Merikangas, K. R.
10.1101/2020.08.24.20181123 — Posted: 2020-08-27
Designing of Epitope-Based Vaccine from the Conserved Region of the Spike Glycoprotein of SARS-CoV-2
Agarwal, V., Tiwari, A., Varadwaj, P. K.
10.1101/2020.08.27.269456 — Posted: 2020-08-27
SARS-CoV-2 Nucleocapsid protein is decorated with multiple N- and O-glycans.
Supekar, N. T., Shajahan, A., Gleinich, A., Rouhani, D., Heiss, C., Azadi, P.
10.1101/2020.08.26.269043 — Posted: 2020-08-27 Discussion: Onsite
Susceptibility of rabbits to SARS-CoV-2
Mykytyn, A. Z., Lamers, M. M., Okba, N. M. A., Breugem, T. I., Schipper, D., van den Doel, P. B., van Run, P., van Amerongen, G., de Waal, L., Koopmans, M., Stittelaar, K. J., van den Brand, J., Haagmans, B. L.
10.1101/2020.08.27.263988 — Posted: 2020-08-27 Discussion: Onsite
Rethinking Remdesivir: Synthesis of Lipid Prodrugs that Substantially Enhance Anti-Coronavirus Activity
Schooley, R. T., Carlin, A. F., Beadle, J. R., Valiaeva, N., Zhang, X.-Q., Garretson, A. F., Smith, V. I., Murphy, J. A., Hostetler, K. Y.
10.1101/2020.08.26.269159 — Posted: 2020-08-27
The immunodominant and neutralization linear epitopes for SARS-CoV-2
Lu, S., Xie, X.-x., Zhao, L., Wang, B., Zhu, J., Yang, T.-r., Yang, G.-w., Ji, M., Lv, C.-p., Xue, J., Dai, E.-h., Fu, X.-m., Liu, D.-q., Zhang, L., Hou, S.-j., Yu, X.-l., Wang, Y.-l., Gao, H.-x., Shi, X.-h., Ke, C.-w., Ke, B.-x., Jiang, C.-g., Liu, R.-t.
10.1101/2020.08.27.267716 — Posted: 2020-08-27 Discussion: Offsite
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice
Karhadkar, T. R., Pilling, D., Gomer, R. H.
10.1101/2020.08.26.269183 — Posted: 2020-08-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).